UTICAJ PANDEMIJE VIRUSA COVID-19 NA UČESTALOST I KLINIČKU PREZENTACIJU DIJABETESA TIPA 1 KOD DECE I ADOLESCENATA: ISKUSTVO JEDNOG CENTRA
Sažetak
Pandemija COVID 19 je drastično promenila funkcionisanje zdravstvenog sistema. Cilj našeg istraživanja je da prikaže incidenciju i kliničku prezentaciju dece i adolescenata sa novootkrivenim tipom 1 šećerne bolesti (DM tip 1) tokom prve godine pandemije COVID 19 i da dobijene podatke uporedi sa prethodnim godinama. Tokom ispitivanog perioda je dijagnostikovan 41 pacijent. Joint point analizom je utvrđen godišnji porast u periodu 2007-2012 (APC 8,94%), praćen smanjenjem broja u periodu od 2012-2015 (APC -6,88%) i statistički značajnim uvećanjem od 2015-2020 (APC 14,20%). Broj dece tokom COVID 19 godine je bio veći, ali bez statističke značajnosti. Procenat dece sa dijabetesnom ketoacidozom (DKA) u vreme postavljanja dijagnoze DM tip 1 u ispitivanom periodu je bio značajno veći nego u prethodnim godinama (84.8% vs 34.6%; p < 0.001). Naši rezultati ukazuju na potencijalno dijabetogeni efekat COVID 19 infekcije. Potrebne su veće i duže studije da bi se utvrdile prave dimenzije ovog uticaja. Drastičan porast DKA u vreme postavljanja dijagnoze DM tip 1 tokom COVID 19 pandemije zahteva poboljšanje preventivnih mera.
Reference
DiMeglio LA, Albanese-O’Neill A, Munoz CE, Maahs DM. COVID-19 and Children With Diabetes-Updates, Unknowns, and Next Steps: First, Do No Extrapola-tion. Diabetes Care 2020;43:2631-4. [CrossRef] [PubMed]
Duca LM, Wang B, Rewers M, Rewers A. Diabetic ketoacidosis at diagnosis of type 1 diabetes predicts poor long-term glycemic control. Diabetes Care 2017; 40(9):1249-55. [CrossRef] [PubMed]
EURODIAB Substudy 2 Study Group. Rapid early growth is associated with increased risk of childhood type 1 diabetes in various European populations. Diabetes Care 2002;25:1755-60. [CrossRef] [PubMed]
European Centre for Disease Prevention and Control. Data on 14-day notification rate of new COVID-19 cases and deaths [dataset]. 2021 april 22nd "cited 2021 april 22nd". Available from: URL: https://www.ecdc.europa.eu/en/publications-data/data-national-14-day-notification-rate-covid-19 .
Fu J, Zhou B, Zhang L, Balaji KS, Wei C, Liu X, et al. Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19. Mol Biol Rep 2020;14:1–10. [CrossRef] [PubMed]
Ho J, Rosolowsky E, Pacaud D, Huang C, Lemay JA, Brockman N, et al. Diabetic ketoacidosis at type 1 diabetes diagnosis in children during the COVID-19 pandemic. Pediatr Diabetes 2021;1-6. [CrossRef] [PubMed]
International Diabetes Federation (Belgium). IDF Dia-betes Atlas. 8th edition. Brussels: International Diabe-tes Federation; 2017.
Jesic MD, Jesic MM, Stanisavljevic D, Zdravkovic V, Bojic V, Vranjes M et al. Ketoacidosis at presentation of type 1 diabetes mellitus in children: a retrospective 20-year experience from a tertiary care hospital in Serbia. Eur J Pediatr 2013;172:1581-5. [CrossRef] [PubMed]
Joinpoint Regression Program (computer program). Version 4.8.0.1. Statistical methodology and applica-tions branch, Surveillance Research Program, National Cancer Institute; 2020.
Li MY, Li L, Zhang Y, Wang XS. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty 2020;9(1):45. [CrossRef] [PubMed]
Sipetic S, Maksimovic J, Vlajinac H, Ratkov I, Sajic S, Zdravkovic D et al. Rising incidence of type 1 diabetes in Belgrade children aged 0-14 years in the period from 1982 to 2005. J Endocrinol Investig 2013; 36:307-12. [PubMed]
Stankovic S, Vukovic R, Vorgucin I, Zdravkovic V, Folic N, Zivic S et al. First report on nationwide prevalence of paediatric type 1 diabetes in Serbia and temporal trends of diabetes ketoacidosis at diagnosis-a multicentre study. J Pediatr Endocrinol Metab 2020; 34(2):225-9. [CrossRef] [PubMed]
The DIAMOND Project Group. Incidence and trends of childhood type 1 diabetes worldwide 1990-1999. Diabet Med 2006;23:857-66. [CrossRef] [PubMed]
Tittel SR, Rosenbauer J, Kamrath C, Ziegler J, Reschke F, Hammersen J, et al. Did the COVID-19 lockdown affect the incidence of pediatric type 1 diabetes in Germany? Diabetes Care 2020;43(11):e172-e173. [CrossRef] [PubMed]
Unsworth R, Wallace S, Oliver NS, Yeung S, Kshirsagar A, Naidu H, et al. New-onset type 1 diabetes in children during COVID-19: multicenter regional findings in the U.K. Diabetes Care 2020; 43(11):e170-e171. [CrossRef] [PubMed]
Vukovic R, Jesic MD, Vorgucin I, Stankovic S, Folic N, Milenkovic T et al. 2018; First report on the nation-wide incidence of type 1 diabetes and ketoacidosis at onset in children in Serbia: a multicenter study. Eur Jour Pediatr 2013;177:1155-62. [CrossRef] [PubMed]
Wolfsdorf JI, Glaser N, Agus M, Fritch M, Hanas R, Rewers A, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and hypergly-caemic hyperosmolar state. Pediatr Diabetes 2018; 19:155-77. [CrossRef] [PubMed]
Yang L, Han Y, Nilsson-Payant BE, Gupta V, Wang P, Duan X, et al. A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids. Cell StemCell 2020;27:125-36.e7. [CrossRef] [PubMed]
You WP, Henneberg M. Type 1 diabetes prevalence increasing globally and regionally: the role of natural selection and life expectancy at birth. BMJ Open Diabetes Res Care 2016;4:e000161. [CrossRef] [PubMed]